San Francisco Chronicle

Con: Health-care price setting needs constraint­s to work

- By Jeffrey Clemens and Benedic Ippolito Jeffrey Clemens is an assistant professor of economics at UC San Diego. Benedic Ippolito is an economist at the American Enterprise Institute.

When tasked with explaining the United States’ exceptiona­lly high spending on health care, a prominent economist was famously succinct: It’s the prices, stupid! Assembly Bill 3087 takes this lesson to heart by proposing direct state regulation of health-care prices. Soberingly, all but one prior effort at this kind of price regulation collapsed. Price setting can under-deliver for many reasons, but its downfall is all but assured if California doesn’t learn from past failures.

The desire to take on health-care prices is understand­able. The United States spends almost 18 percent of gross domestic product on health care — nearly twice that of many other wealthy countries. California, with nearly $300 billion per year in healthcare spending alone, is no exception. Yet Americans spend more, not because they use more, but because they pay higher prices.

AB3087 proposes to task an independen­t state agency with setting payment rates for all health-care providers. Such authority conveys substantia­l power to alter the market. However, the temptation for regulators to overreach presents a threat to rate setting’s success.

Economists typically balk at this kind of highly regulated price setting. When markets work well, prices serve as signals of evolving costs, needs and wants: informatio­n even the most competent and benevolent regulator cannot feasibly possess. Indeed, evidence from Medicare suggests that regulated prices tend to adapt very slowly to evolving conditions. This blunts the incentives of providers to improve or even maintain their quality, and generally fails to encourage high-value care.

Of course, health-care markets differ from well-functionin­g markets in crucial ways. A growing body of evidence highlights the important role played by the market power of insurance companies, health-care providers and Medicare in shaping private health-care prices. Furthermor­e, because insurance shields consumers from cost, price shopping seems unlikely to become a central driver of cost control. These distortion­s imply that health-care falls short of economists’ competitiv­e-market benchmark. Payment regulation is more viable in this setting than in most others.

Fortunatel­y, the potential effectiven­ess of health-care payment regulation need not be litigated based on theory alone. During the 1970s and 1980s, more than half of the states introduced some form of hospital price regulation or budget oversight. A handful of these states ran all-payer price-setting systems, not unlike the one just proposed for California.

So why did nearly all these systems unravel?

Our own research showed a common thread across failures is that policymake­rs reached beyond their mandate to control costs and increase transparen­cy. States succumbed to the temptation to use their rate-setting authority as a piggy bank for generating revenue and as an opportunit­y to pick winners and losers among insurers and health-care providers.

The loopholes and cross-subsidy schemes of the past reflected combinatio­ns of interest-group politics and ill-designed, though well-intentione­d, efforts to finance care for the poor. Our work shows that these efforts sowed the seeds of instabilit­y in past rate-setting regimes. These systems were, with one exception, abandoned.

The sole surviving rate-setting regime can be found in Maryland, and it’s instructiv­e in its own right. While often lauded for being well run, Maryland’s system has a second, perhaps decisive, advantage: It has a longstandi­ng federal subsidy recently valued at more than $1.5 billion per year (thanks to higher Medicare and Medicaid payments). Such a large sweetener, courtesy of federal taxpayers, is arguably the glue that has kept the Maryland system from fraying at the edges.

If California­ns want to give rate regulation an opportunit­y to succeed, they must call on their legislator­s to erect guardrails on regulators’ future authority. If rate-setting authoritie­s are insufficie­ntly constraine­d, history reveals that the goals of cost control and transparen­cy are likely to be lost.

Newspapers in English

Newspapers from United States